treating < treatment < treatments

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references

Number of relevant bibliographic references: 198.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000001 (2020)	Luca Quartuccio [Italie] ; Luca Semerano [France] ; Maurizio Benucci [Italie] ; Marie-Christophe Boissier [France] ; Salvatore De Vita [Italie]	Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome
000011 (2020)	Charlotte Borocco [France] ; Claire Ballot-Schmit [France] ; Oanez Ackermann [France] ; Nathalie Aladjidi [France] ; Jeremie Delaleu [France] ; Vannina Giacobbi-Milet [France] ; Sarah Jannier [France] ; Eric Jeziorski [France] ; François Maurier [France] ; Yves Perel [France] ; Christophe Piguet [France] ; Eric Oksenhendler [France] ; Isabelle Koné-Paut [France] ; Caroline Galeotti [France]	The French paediatric cohort of Castleman disease: a retrospective report of 23 patients
000012 (2020)	Chayma Ladhari [France] ; Pierre Le Blay [France] ; Thierry Vincent [France] ; Ahmed Larbi [France] ; Emma Rubenstein [France] ; Rosanna Ferreira Lopez [France] ; Christian Jorgensen [France] ; Yves-Marie Pers [France]	Successful long-term remission through tapering tocilizumab infusions: a single-center prospective study
000013 (2020)	Cem Gabay [Suisse] ; Gerd R. Burmester [Allemagne] ; Vibeke Strand [États-Unis] ; Jérôme Msihid [France] ; Moshe Zilberstein [États-Unis] ; Toshio Kimura [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Susan H. Boklage [États-Unis] ; Jonathan Sadeh [États-Unis] ; Neil M. H. Graham [États-Unis] ; Anita Boyapati [États-Unis]	Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes
000020 (2020)	Laure Elens [Belgique] ; Loralie J. Langman [États-Unis] ; Dennis A. Hesselink ; Stein Bergan [Norvège] ; Dirk Jan A. R. Moes ; Mariadelfina Molinaro [Italie] ; Raman Venkataramanan [États-Unis] ; Florian Lemaitre [France]	Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions
000022 (2020)	Ibrahim Yakoub-Agha [France] ; Christian Chabannon [France] ; Peter Bader [Allemagne] ; Grzegorz W. Basak [Pologne] ; Halvard Bonig [Allemagne] ; Fabio Ciceri [Italie] ; Selim Corbacioglu [Allemagne] ; Rafael F. Duarte [Espagne] ; Hermann Einsele [Allemagne] ; Michael Hudecek [Allemagne] ; Marie José Kersten [Pays-Bas] ; Ulrike Köhl [Allemagne] ; Jürgen Kuball [Pays-Bas] ; Stephan Mielke [Suède] ; Mohamad Mohty [France] ; John Murray [Royaume-Uni] ; Arnon Nagler [Israël] ; Stephen Robinson [Royaume-Uni] ; Riccardo Saccardi [Italie] ; Fermin Sanchez-Guijo [Espagne] ; John A. Snowden [Royaume-Uni] ; Micha Srour [France] ; Jan Styczynski [Pologne] ; Alvaro Urbano-Ispizua [Espagne] ; Patrick J. Hayden [Irlande (pays)] ; Nicolaus Kröger [Allemagne]	Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
000025 (2020)	Florian Moretto ; François-Xavier Catherine ; Clémentine Esteve ; Mathieu Blot [France] ; Lionel Piroth [France]	Isolated Anti-HBc: Significance and Management
000028 (2020)	Amin Gasmi [France] ; Sadaf Noor [Pakistan] ; Torsak Tippairote [Thaïlande] ; Maryam Dadar [Iran] ; Alain Menzel [France] ; Geir Bj Rklund [Norvège]	Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic
000032 (2020)	Charlotte Hua [France] ; Frank Buttgereit [Allemagne] ; Bernard Combe [France]	Glucocorticoids in rheumatoid arthritis: current status and future studies
000033 (2020)	Jacqueline M. Tarrant [États-Unis] ; René Galien [France] ; Wanying Li [États-Unis] ; Lovely Goyal [États-Unis] ; Yang Pan [États-Unis] ; Rachael Hawtin [États-Unis] ; Wangshu Zhang [États-Unis] ; Annegret Van Der Aa [Belgique] ; Peter C. Taylor [Royaume-Uni]	Filgotinib, a JAK1 Inhibitor, Modulates Disease-Related Biomarkers in Rheumatoid Arthritis: Results from Two Randomized, Controlled Phase 2b Trials
000035 (2020)	Andreas Kerschbaumer [Autriche] ; Alexandre Sepriano [Pays-Bas] ; Josef S. Smolen [Autriche] ; Désirée Van Der Heijde [Pays-Bas] ; Maxime Dougados [France] ; Ronald Van Vollenhoven [Pays-Bas] ; Iain B. Mcinnes [Royaume-Uni] ; Johannes W J. Bijlsma [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Maarten De Wit [Suisse] ; Louise Falzon [États-Unis] ; Robert Landewé [Pays-Bas]	Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis.
000036 (2020)	Lutz Wollin [Allemagne] ; Dieudonnée Togbe [France] ; Bernhard Ryffel [France]	Effects of Nintedanib in an Animal Model of Liver Fibrosis
000038 (2020)	Salah Ghabri [France] ; Aymeric Binard [France] ; Yves-Marie Pers [France] ; Franck Maunoury [France] ; J Jaime Caro [États-Unis]	Economic Evaluation of Sequences of Biological Treatments for Patients With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response or Intolerance to Methotrexate in France.
000045 (2020)	Charlotte Laurent [France] ; Zora Marjanovic [France] ; Laure Ricard [France] ; Joerg Henes [Allemagne] ; Remy Dulery [France] ; Manuela Badoglio [France] ; Dominique Farge [France] ; John A. Snowden [Royaume-Uni] ; Daniela Moraes [Brésil] ; Juliana Dias [Brésil] ; Mohamad Mohty [France] ; Michael Soussan [France] ; Olivier Fain [France] ; Renate Arnold [Allemagne] ; Tobias Alexander [Allemagne] ; Maria-Carolina Oliveira [Brésil] ; Arsène Mekinian [France]	Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in refractory Takayasu arteritis: a retrospective multicenter case-series from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT).
000054 (2019)	Maxime Samson [France] ; Hélène Greigert [France] ; Thibault Ghesquière [France] ; Bernard Bonnotte [France]	[Treatment of giant cell arteritis].
000057 (2019)	Christoph Lohan [Royaume-Uni] ; Alex Diamantopoulos [Royaume-Uni] ; Corinne Lereun [France] ; Emily Wright [Royaume-Uni] ; Natalie Bohm [Royaume-Uni] ; Laura Marie Sawyer [Royaume-Uni]	Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation
000068 (2019)	Emma L. Simpson [Royaume-Uni] ; Shijie Ren [Royaume-Uni] ; Emma S. Hock [Royaume-Uni] ; John W. Stevens [Royaume-Uni] ; Aymeric Binard [France] ; Yves-Marie Pers [France] ; Rachel Archer [Royaume-Uni] ; Suzy Paisley [Royaume-Uni] ; Matthew D. Stevenson [Royaume-Uni] ; Chloé Herpin [France] ; Salah Ghabri [France]	Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis.
000082 (2019)	Manuela Pardeo [Italie] ; Jianmei Wang [Royaume-Uni] ; Nicolino Ruperto [Italie] ; Ekaterina Alexeeva [Russie] ; Vyacheslav Chasnyk [Russie] ; Rayfel Schneider [Canada] ; Gerd Horneff [Allemagne] ; Hans-Iko Huppertz [Allemagne] ; Kirsten Minden [Allemagne] ; Karen Onel [États-Unis] ; Lawrence Zemel [États-Unis] ; Alan Martin [États-Unis] ; Isabelle Koné-Paut [France] ; Antigoni Siamopoulou-Mavridou [Grèce] ; Clovis A. Silva [Brésil] ; Benjamin Porter-Brown [Royaume-Uni] ; Kamal N. Bharucha [États-Unis] ; Hermine I. Brunner [États-Unis] ; Fabrizio De Benedetti [Italie]	Neutropenia During Tocilizumab Treatment Is Not Associated with Infection Risk in Systemic or Polyarticular-course Juvenile Idiopathic Arthritis.
000086 (2019)	Marion Bossennec [France] ; Céline Rodriguez [France] ; Margaux Hubert [France] ; Anthony Di-Roio [France] ; Christelle Machon [France] ; Jérôme Guitton [France] ; Priscilla Battiston-Montagne [France] ; Mathilde Couturier ; Hubert Marotte [France] ; Christophe Caux [France] ; Fabienne Coury [France] ; Christine Ménétrier-Caux [France]	Methotrexate Restores CD73 Expression on Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis Patients and May Contribute to Its Anti-Inflammatory Effect through Ado Production
000087 (2019)	Noymar Luque-Campos [Chili] ; Rafael A. Contreras-L Pez [Chili] ; María Jose Paredes-Martínez [Chili] ; Maria Jose Torres [Chili] ; Sarah Bahraoui [France] ; Mingxing Wei [France] ; Francisco Espinoza [Chili] ; Farida Djouad [France] ; Roberto Javier Elizondo-Vega [Chili] ; Patricia Luz-Crawford [Chili]	Mesenchymal Stem Cells Improve Rheumatoid Arthritis Progression by Controlling Memory T Cell Response
000093 (2019)	Chloé Laplagne [France] ; Marcin Domagala [France] ; Augustin Le Naour [France] ; Christophe Quemerais [France] ; Dimitri Hamel [France] ; Jean-Jacques Fournié [France] ; Bettina Couderc [France] ; Corinne Bousquet [France] ; Audrey Ferrand [France] ; Mary Poupot [France]	Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/AbsEn.i -k "treatment" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/AbsEn.i  \
                -Sk "treatment" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    treatment
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021